HCA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Hca Healthcare Inc (HCA).


$76.03B Market Cap.

As of 02/14/2025 5:00 PM ET (MRY) • Disclaimer

HCA Market Cap. (MRY)


HCA Shares Outstanding (MRY)


HCA Assets (MRY)


Total Assets

$59.51B

Total Liabilities

$58.96B

Total Investments

$1.23B

HCA Income (MRY)


Revenue

$70.60B

Net Income

$5.76B

Operating Expense

$18.13B

HCA Cash Flow (MRY)


CF Operations

$10.51B

CF Investing

-$4.93B

CF Financing

-$4.58B

HCA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$2.64

0.90%

10.00%

11.85%

8.44

2023

$2.40

0.90%

7.14%

12.47%

8.02

2022

$2.24

0.90%

16.67%

11.53%

8.67

2021

$1.92

0.70%

149.35%

8.92%

11.21

2020

$0.77

0.50%

-

6.94%

14.42

HCA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$59,513,000,000 (5.87%)

$56,211,000,000 (7.20%)

$52,438,000,000 (3.34%)

$50,742,000,000 (6.85%)

Assets Current

$16,414,000,000 (9.96%)

$14,927,000,000 (9.41%)

$13,643,000,000 (0.75%)

$13,542,000,000 (9.80%)

Assets Non-Current

$43,099,000,000 (4.40%)

$41,284,000,000 (6.42%)

$38,795,000,000 (4.29%)

$37,200,000,000 (5.81%)

Goodwill & Intangible Assets

$10,093,000,000 (1.49%)

$9,945,000,000 (3.02%)

$9,653,000,000 (1.18%)

$9,540,000,000 (11.21%)

Shareholders Equity

-$2,499,000,000 (-40.87%)

-$1,774,000,000 (35.89%)

-$2,767,000,000 (-196.57%)

-$933,000,000 (-263.11%)

Property Plant & Equipment Net

$31,545,000,000 (5.42%)

$29,922,000,000 (8.26%)

$27,640,000,000 (5.59%)

$26,176,000,000 (3.78%)

Cash & Equivalents

$1,933,000,000 (106.74%)

$935,000,000 (2.97%)

$908,000,000 (-37.42%)

$1,451,000,000 (-19.07%)

Accumulated Other Comprehensive Income

-$387,000,000 (8.94%)

-$425,000,000 (13.27%)

-$490,000,000 (-21.29%)

-$404,000,000 (19.52%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$1,231,000,000 (-0.16%)

$1,233,000,000 (2.41%)

$1,204,000,000 (35.89%)

$886,000,000 (9.38%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$1,231,000,000 (-0.16%)

$1,233,000,000 (2.41%)

$1,204,000,000 (35.89%)

$886,000,000 (9.38%)

Inventory

$1,738,000,000 (-14.00%)

$2,021,000,000 (-2.27%)

$2,068,000,000 (4.13%)

$1,986,000,000 (-1.93%)

Trade & Non-Trade Receivables

$10,751,000,000 (7.96%)

$9,958,000,000 (12.00%)

$8,891,000,000 (9.83%)

$8,095,000,000 (14.81%)

Trade & Non-Trade Payables

$4,276,000,000 (1.02%)

$4,233,000,000 (-0.14%)

$4,239,000,000 (3.11%)

$4,111,000,000 (16.29%)

Accumulated Retained Earnings (Deficit)

-$2,115,000,000 (-56.43%)

-$1,352,000,000 (40.70%)

-$2,280,000,000 (-328.57%)

-$532,000,000 (-168.47%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$2,041,000,000 (9.32%)

$1,867,000,000 (15.60%)

$1,615,000,000 (-21.60%)

$2,060,000,000 (6.19%)

Total Debt

$44,894,000,000 (8.19%)

$41,496,000,000 (4.17%)

$39,836,000,000 (9.64%)

$36,334,000,000 (11.19%)

Debt Current

$4,698,000,000 (93.81%)

$2,424,000,000 (555.14%)

$370,000,000 (56.12%)

$237,000,000 (13.40%)

Debt Non-Current

$40,196,000,000 (2.88%)

$39,072,000,000 (-1.00%)

$39,466,000,000 (9.33%)

$36,097,000,000 (11.18%)

Total Liabilities

$58,958,000,000 (6.90%)

$55,151,000,000 (5.03%)

$52,511,000,000 (6.61%)

$49,253,000,000 (10.44%)

Liabilities Current

$15,177,000,000 (19.93%)

$12,655,000,000 (27.80%)

$9,902,000,000 (3.34%)

$9,582,000,000 (10.09%)

Liabilities Non-Current

$43,781,000,000 (3.02%)

$42,496,000,000 (-0.27%)

$42,609,000,000 (7.41%)

$39,671,000,000 (10.52%)

HCA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$70,603,000,000 (8.67%)

$64,968,000,000 (7.86%)

$60,233,000,000 (2.52%)

$58,752,000,000 (14.01%)

Cost of Revenue

$41,925,000,000 (6.44%)

$39,389,000,000 (6.30%)

$37,056,000,000 (2.20%)

$36,260,000,000 (12.46%)

Selling General & Administrative Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$18,131,000,000 (13.66%)

$15,952,000,000 (12.94%)

$14,124,000,000 (10.22%)

$12,814,000,000 (6.53%)

Interest Expense

$2,061,000,000 (6.35%)

$1,938,000,000 (11.32%)

$1,741,000,000 (11.17%)

$1,566,000,000 (-1.14%)

Income Tax Expense

$1,866,000,000 (15.54%)

$1,615,000,000 (-7.50%)

$1,746,000,000 (-17.33%)

$2,112,000,000 (102.49%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$6,657,000,000 (9.29%)

$6,091,000,000 (-10.87%)

$6,834,000,000 (-11.49%)

$7,721,000,000 (76.00%)

Net Income to Non-Controlling Interests

$897,000,000 (5.65%)

$849,000,000 (-28.72%)

$1,191,000,000 (55.69%)

$765,000,000 (20.85%)

Net Income

$5,760,000,000 (9.88%)

$5,242,000,000 (-7.11%)

$5,643,000,000 (-18.88%)

$6,956,000,000 (85.30%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$5,760,000,000 (9.88%)

$5,242,000,000 (-7.11%)

$5,643,000,000 (-18.88%)

$6,956,000,000 (85.30%)

Weighted Average Shares

$258,603,000 (-5.07%)

$272,404,000 (-6.18%)

$290,348,000 (-10.20%)

$323,315,000 (-4.42%)

Weighted Average Shares Diluted

$261,806,000 (-5.28%)

$276,412,000 (-6.19%)

$294,666,000 (-10.37%)

$328,752,000 (-4.32%)

Earning Before Interest & Taxes (EBIT)

$9,687,000,000 (10.14%)

$8,795,000,000 (-3.67%)

$9,130,000,000 (-14.14%)

$10,634,000,000 (66.65%)

Gross Profit

$28,678,000,000 (12.12%)

$25,579,000,000 (10.36%)

$23,177,000,000 (3.05%)

$22,492,000,000 (16.60%)

Operating Income

$10,547,000,000 (9.56%)

$9,627,000,000 (6.34%)

$9,053,000,000 (-6.46%)

$9,678,000,000 (33.27%)

HCA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$4,933,000,000 (7.22%)

-$5,317,000,000 (-56.89%)

-$3,389,000,000 (-28.23%)

-$2,643,000,000 (22.10%)

Net Cash Flow from Financing

-$4,582,000,000 (-11.92%)

-$4,094,000,000 (27.62%)

-$5,656,000,000 (15.01%)

-$6,655,000,000 (-42.29%)

Net Cash Flow from Operations

$10,514,000,000 (11.48%)

$9,431,000,000 (10.67%)

$8,522,000,000 (-4.88%)

$8,959,000,000 (-2.96%)

Net Cash Flow / Change in Cash & Cash Equivalents

$998,000,000 (3596.30%)

$27,000,000 (104.97%)

-$543,000,000 (-58.77%)

-$342,000,000 (-129.18%)

Net Cash Flow - Business Acquisitions and Disposals

$62,000,000 (114.03%)

-$442,000,000 (-143.63%)

$1,013,000,000 (-3.98%)

$1,055,000,000 (311.00%)

Net Cash Flow - Investment Acquisitions and Disposals

-$115,000,000 (-2.68%)

-$112,000,000 (-900.00%)

$14,000,000 (111.97%)

-$117,000,000 (-485.00%)

Capital Expenditure

-$4,875,000,000 (-2.76%)

-$4,744,000,000 (-7.94%)

-$4,395,000,000 (-22.87%)

-$3,577,000,000 (-26.17%)

Issuance (Repayment) of Debt Securities

$3,138,000,000 (148.26%)

$1,264,000,000 (-60.92%)

$3,234,000,000 (0.53%)

$3,217,000,000 (198.92%)

Issuance (Purchase) of Equity Shares

-$6,042,000,000 (-58.54%)

-$3,811,000,000 (45.56%)

-$7,000,000,000 (14.79%)

-$8,215,000,000 (-1762.81%)

Payment of Dividends & Other Cash Distributions

-$690,000,000 (-4.39%)

-$661,000,000 (-1.23%)

-$653,000,000 (-4.65%)

-$624,000,000 (-307.84%)

Effect of Exchange Rate Changes on Cash

-$1,000,000 (-114.29%)

$7,000,000 (135.00%)

-$20,000,000 (-566.67%)

-$3,000,000 (-130.00%)

Share Based Compensation

$360,000,000 (37.40%)

$262,000,000 (-23.17%)

$341,000,000 (-22.50%)

$440,000,000 (21.55%)

Depreciation Amortization & Accretion

$3,312,000,000 (7.64%)

$3,077,000,000 (3.64%)

$2,969,000,000 (4.07%)

$2,853,000,000 (4.85%)

HCA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

40.60% (3.05%)

39.40% (2.34%)

38.50% (0.52%)

38.30% (2.41%)

Profit Margin

8.20% (1.23%)

8.10% (-13.83%)

9.40% (-20.34%)

11.80% (61.64%)

EBITDA Margin

18.40% (0.55%)

18.30% (-8.96%)

20.10% (-12.61%)

23.00% (29.94%)

Return on Average Equity (ROAE)

-291.80% (-25.94%)

-231.70% (-21.63%)

-190.50% (86.48%)

-1409.50% (-383.37%)

Return on Average Assets (ROAA)

9.90% (2.06%)

9.70% (-11.01%)

10.90% (-23.24%)

14.20% (82.05%)

Return on Sales (ROS)

13.70% (1.48%)

13.50% (-11.18%)

15.20% (-16.02%)

18.10% (45.97%)

Return on Invested Capital (ROIC)

12.80% (5.79%)

12.10% (-5.47%)

12.80% (-22.89%)

16.60% (53.70%)

Dividend Yield

0.90% (0.00%)

0.90% (0.00%)

0.90% (28.57%)

0.70% (40.00%)

Price to Earnings Ratio (P/E)

13.48 (-4.15%)

14.06 (13.85%)

12.35 (3.44%)

11.94 (-19.42%)

Price to Sales Ratio (P/S)

1.1 (-3.17%)

1.14 (-1.90%)

1.16 (-18.18%)

1.41 (30.93%)

Price to Book Ratio (P/B)

-30.42 (25.51%)

-40.84 (-66.57%)

-24.52 (71.37%)

-85.65 (-188.03%)

Debt to Equity Ratio (D/E)

-23.59 (24.11%)

-31.09 (-63.82%)

-18.98 (64.05%)

-52.79 (-167.71%)

Earnings Per Share (EPS)

22.27 (15.69%)

19.25 (-0.93%)

19.43 (-9.71%)

21.52 (93.87%)

Sales Per Share (SPS)

273.02 (14.47%)

238.5 (14.97%)

207.45 (14.16%)

181.72 (19.28%)

Free Cash Flow Per Share (FCFPS)

21.81 (26.73%)

17.21 (21.05%)

14.21 (-14.61%)

16.65 (-11.98%)

Book Value Per Share (BVPS)

-9.66 (-48.39%)

-6.51 (31.67%)

-9.53 (-230.21%)

-2.89 (-270.67%)

Tangible Assets Book Value Per Share (TABVPS)

191.1 (12.52%)

169.84 (15.26%)

147.36 (15.63%)

127.44 (10.78%)

Enterprise Value Over EBIT (EV/EBIT)

12 (-7.69%)

13 (8.33%)

12 (9.09%)

11 (-15.38%)

Enterprise Value Over EBITDA (EV/EBITDA)

9.08 (-4.33%)

9.49 (8.01%)

8.79 (4.94%)

8.37 (-6.68%)

Asset Turnover

1.21 (1.09%)

1.2 (3.19%)

1.16 (-3.41%)

1.2 (12.24%)

Current Ratio

1.08 (-8.31%)

1.18 (-14.37%)

1.38 (-2.48%)

1.41 (-0.28%)

Dividends

$2.64 (10.00%)

$2.4 (7.14%)

$2.24 (16.67%)

$1.92 (149.35%)

Free Cash Flow (FCF)

$5,639,000,000 (20.31%)

$4,687,000,000 (13.57%)

$4,127,000,000 (-23.32%)

$5,382,000,000 (-15.87%)

Enterprise Value (EV)

$118,028,124,565 (4.74%)

$112,681,425,344 (5.99%)

$106,313,699,332 (-5.85%)

$112,921,977,776 (38.28%)

Earnings Before Tax (EBT)

$7,626,000,000 (11.21%)

$6,857,000,000 (-7.20%)

$7,389,000,000 (-18.52%)

$9,068,000,000 (89.03%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$12,999,000,000 (9.49%)

$11,872,000,000 (-1.88%)

$12,099,000,000 (-10.29%)

$13,487,000,000 (48.18%)

Invested Capital

$77,204,000,000 (4.09%)

$74,172,000,000 (3.29%)

$71,811,000,000 (7.98%)

$66,503,000,000 (8.86%)

Working Capital

$1,237,000,000 (-45.55%)

$2,272,000,000 (-39.27%)

$3,741,000,000 (-5.53%)

$3,960,000,000 (9.12%)

Tangible Asset Value

$49,420,000,000 (6.82%)

$46,266,000,000 (8.14%)

$42,785,000,000 (3.84%)

$41,202,000,000 (5.89%)

Market Capitalization

$76,027,124,565 (4.94%)

$72,450,425,344 (6.79%)

$67,840,699,332 (-15.10%)

$79,907,977,776 (43.59%)

Average Equity

-$1,974,000,000 (12.74%)

-$2,262,250,000 (23.64%)

-$2,962,500,000 (-500.30%)

-$493,500,000 (61.67%)

Average Assets

$58,328,250,000 (7.47%)

$54,276,250,000 (4.52%)

$51,928,500,000 (6.11%)

$48,936,250,000 (1.61%)

Invested Capital Average

$75,878,250,000 (4.33%)

$72,728,500,000 (2.27%)

$71,111,500,000 (11.02%)

$64,055,500,000 (8.70%)

Shares

253,297,100 (-5.37%)

267,660,800 (-5.33%)

282,716,700 (-9.10%)

311,022,800 (-8.08%)